Research Development Assistant
Validation of the HULL Score clinical prediction rule for unsuspected pulmonary embolism in ambulatory cancer patients
Haque, F., Ryde, J., Broughton, L., Huang, C., Sethi, S., Stephens, A., …Maraveyas, A. (2023). Validation of the HULL Score clinical prediction rule for unsuspected pulmonary embolism in ambulatory cancer patients. ERJ Open Research, 9(3), Article 00651-2022. https://doi.org/10.1183/23120541.00651-2022
Duramycin-porphyrin conjugates for targeting of tumour cells using photodynamic therapy
Broughton, L. J., Giuntini, F., Savoie, H., Bryden, F., Boyle, R. W., Maraveyas, A., & Madden, L. A. (2016). Duramycin-porphyrin conjugates for targeting of tumour cells using photodynamic therapy. Journal of photochemistry and photobiology. B, Biology, 163, 374-384. https://doi.org/10.1016/j.jphotobiol.2016.09.001
Duramycin-induced calcium release in cancer cells
Broughton, L. J., Crow, C., Madden, L. A., & Maraveyas, A. (2016). Duramycin-induced calcium release in cancer cells. Anti-cancer drugs, 27(3), 173-182. https://doi.org/10.1097/cad.0000000000000313
Targeting phosphatidylethanolamine on tumour cells using duramycin
Broughton, L. (2014). Targeting phosphatidylethanolamine on tumour cells using duramycin. Thrombosis Research, 133(Supplement 2), S213-S213. https://doi.org/10.1016/s0049-3848%2814%2950032-1
Project
Funder
Grant
Started
Status
Hull University Teaching Hospitals NHS Trust
£135,070.00
1 January 2024
Ongoing
£119,149.00
£89,343.00
1 September 2024
Centre for Clinical Sciences
Browser does not support script.